近日,《美国医学会杂志-眼科学》(JAMA)发布的一篇研究论文指出,有患者在使用诺和诺德的司美格鲁肽或者礼来的替尔泊肽等GLP-1类药物后出现了眼部的并发症,如非动脉炎性前部缺血性视神经病变(NAION)、视盘血管炎,以及黄斑旁中心中层视网膜病变(PAMM)。 公开资料显示,NAION是临床上一种急性视神经病变,严重危害视功能,表现为急性、典型的单侧和无痛性视力丧失、同侧相对性传入瞳孔缺陷(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.